Back to Search
T. WINHUSEN, PH.D.
PH.D.
Psychologist
NPI: 1659501344Individual
Specialties, Licenses & Credentials
PsychologistPrimary
Psychologist
Code: 103T00000X
5568(OH)
Research & Publications (18)
Motivational enhancement therapy to improve treatment utilization and outcome in pregnant substance users.
PMID 18083322·J Subst Abuse Treat·2008
2-rct
A double-blind, placebo-controlled trial of tiagabine for the treatment of cocaine dependence.
PMID 17629631·Drug Alcohol Depend·2007
4-observational
A double-blind, placebo-controlled trial of reserpine for the treatment of cocaine dependence.
PMID 17628352·Drug Alcohol Depend·2007
2-rct
Methylphenidate and cocaine: a placebo-controlled drug interaction study.
PMID 16916538·Pharmacol Biochem Behav·2006
2-rct
Metyrapone and cocaine: a double-blind, placebo-controlled drug interaction study.
PMID 15820533·Pharmacol Biochem Behav·2005
3-trial
A placebo-controlled screening trial of tiagabine, sertraline and donepezil as cocaine dependence treatments.
PMID 15730351·Addiction·2005
3-trial
Psychosocial treatments for women with substance use disorders.
PMID 14664323·Obstet Gynecol Clin North Am·2003
6-review
Measuring outcome in cocaine clinical trials: a comparison of sweat patches with urine toxicology and participant self-report.
PMID 12603231·Addiction·2003
3-trial
The HPA axis in cocaine use: implications for pharmacotherapy.
PMID 11681586·J Addict Dis·2001
6-review
Incentives for retention of pregnant substance users: a secondary analysis.
PMID 19577405·J Subst Abuse Treat·2010
2-rct
Motivation Enhancement Therapy with pregnant substance-abusing women: does baseline motivation moderate efficacy?
PMID 19101099·Drug Alcohol Depend·2009
2-rct
Predictors of outcome for short-term medically supervised opioid withdrawal during a randomized, multicenter trial of buprenorphine-naloxone and clonidine in the NIDA clinical trials network drug and alcohol dependence.
PMID 18805656·Drug Alcohol Depend·2009
4-observational
The SRPHK1 outcome measure for cocaine-dependence trials combines self-report, urine benzoylecgonine levels, and the concordance between the two to determine a cocaine-use status for each study day.
PMID 18029115·Drug Alcohol Depend·2008
2-rct
Using buprenorphine short-term taper to facilitate early treatment engagement.
PMID 17481458·J Subst Abuse Treat·2007
4-observational
Cocaine Rapid Efficacy Screening Trials (CREST): lessons learned.
PMID 15730354·Addiction·2005
8-other
A medication screening trial evaluation of reserpine, gabapentin and lamotrigine pharmacotherapy of cocaine dependence.
PMID 15730350·Addiction·2005
3-trial
Bringing buprenorphine-naloxone detoxification to community treatment providers: the NIDA Clinical Trials Network field experience.
PMID 15204675·Am J Addict·2004
8-other
An open-label pilot study of methylphenidate in the treatment of cocaine dependent patients with adult attention deficit/hyperactivity disorder.
PMID 15077842·J Addict Dis·2004
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3131 HARVEY AVE
CINCINNATI, OH 45229 - Phone
- (513) 585-8227
Quick Facts
- NPI
- 1659501344
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 18
Are you this provider?
Claim Your Profile